EDIT Editas Medicine, Inc. - Common Stock
Editas Medicine, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
और पढ़ें
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
History
Editas Medicine was originally founded with the name "Gengine, Inc." in September 2013 by Feng Zhang of the Broad Institute, Jennifer Doudna of the University of California, Berkeley, and George Church, David Liu, and J. Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures. The name was changed to the current "Editas Medicine" two months later. Doudna quit in June 2014 over legal differences concerning intellectual property of Cas9.
In August 2015, the company raised $120 million in Series B funding from Bill Gates and 13 other investors. it went public on 2 February 2016, via a $94 million initial public offering.
Editas entered into a strategic collaboration with Juno Therapeutics in 2015 to create a chimeric antigen receptor and high-affinity T cell receptor therapeutics to the end of developing cancer therapeutics. Juno was later acquired by Celgene, which was in turn acquired by Bristol Myers Squibb.
The company announced in 2015 that it was planning a clinical trial using CRISPR gene editing techniques to treat Leber congenital amaurosis type 10 (LCA10), a rare genetic illness that causes blindness. On 30 November 2018, the FDA gave permission to start the trials, under the investigational name EDIT-101 (also known as AGN-151587). In September 2021, a statement from Editas claimed that preliminary results from clinical trials were promising and support clinical benefits of EDIT-101 treatment.
In March 2020, Editas, in partnership with Allergan, was the first to use CRISPR to try to edit DNA inside a person's body (in vivo). As part of the clinical trial, a patient who was nearly blind as a result of Leber's congenital amaurosis received an intravitreal injection containing a harmless virus carrying CRISPR gene-editing instructions. Five months later, Editas reworked its deal with Allergan's owner AbbVie and regained full rights to their range of eye disease treatment therapies, including EDIT-101 for the treatment of LCA10.
In 2019, the company was building new chemistry facilities in Boulder, Colorado.
Katrine Bosley was CEO until 2019, when she was replaced by board member Cynthia Collins. Collins was replaced in 2021 by James Mullen, who had been board chairman. Gilmore O'Neill, former CMO of Sarepta Therapeutics, became CEO on June 1, 2022, with Mullen staying on as executive chairman of the board.
On December 12, 2024, Editas ended the development of reni-cel and laid off 65% of its employees.
Research
Editas works with two different CRISPR nucleases, Cas9 and Cas12a.
EDIT-101 is a CRISPR based gene therapy for treatment of Leber congenital amaurosis, currently in clinical trials.
EDIT-301 is an experimental potential treatment utilizing the firm's CAS 12a editing technology for sickle cell disease and beta-thalassemia. In 2019 the firm reported early success in research on the drug;. In December 2020, it filed an IND application for treatment of sickle cell disease. In January 2021, it said it had received clearance from the FDA for phase 1 safety studies.
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
EDIT स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
EDIT स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
EDIT विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
- मजबूत खरीद 4 22.2%
- खरीदें 8 44.4%
- होल्ड 4 22.2%
- बेचें 2 11.1%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
9 विश्लेषक · 2026-08-23Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $-0.15 | $-0.28 | 0.13% |
| 31 मार्च 2026 | $-0.26 | $-0.27 | 0.01% |
| 31 दिसमबर 2025 | $-0.06 | $-0.26 | 0.20% |
| 30 सितमबर 2025 | $-0.28 | $-0.30 | 0.02% |
| 30 जून 2025 | $-0.63 | $-0.38 | -0.25% |
| 31 मार्च 2025 | $-0.92 | $-0.60 | -0.32% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 13
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $32M | $78M | $20M | $26M | $91M | $21M | $32M | $14M | $6M | |
| R&D Expense | $90M | $199M | $178M | $175M | $143M | $158M | $97M | $91M | $83M | $57M | |
| SG&A Expense | $50M | $72M | $70M | $71M | $76M | $68M | $65M | $55M | $51M | $46M | |
| Operating Expenses | $201M | $283M | $247M | $246M | $219M | $226M | $161M | $146M | $134M | $103M | |
| Operating Income | $-160M | $-251M | $-169M | $-226M | $-193M | $-135M | $-141M | $-114M | $-120M | $-97M | |
| Other Non-op | $-2M | $-3.0K | $-2M | $0 | $37.0K | $16M | $-137.0K | $328.0K | $587.0K | $-57.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-160M | $-237M | $-153M | $-220M | $-193M | $-116M | $-134M | $-110M | $-120M | $-97M | |
| EPS (Basic) | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 | $-1.98 | $-2.68 | · | · | · | |
| EPS (Diluted) | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 | $-1.98 | $-2.68 | · | · | · | |
| Shares (Basic) | 88,745,908 | 82,338,220 | 75,965,633 | 68,664,822 | 67,619,388 | 58,609,389 | 49,983,329 | · | · | · | |
| Shares (Diluted) | 88,745,908 | 82,338,220 | 75,965,633 | 68,664,822 | 67,619,388 | 58,609,389 | 49,983,329 | · | · | · | |
| EBITDA | $-160M | $-251M | $-169M | $-226M | $-193M | $-135M | $-141M | $-114M | $-120M | $-97M |
बैलेंस शीट 24
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $147M | $132M | $124M | $142M | $204M | $140M | $238M | $135M | $147M | $185M | |
| Short-term Investments | $0 | $138M | $199M | $203M | $296M | $262M | $219M | $234M | $183M | · | |
| Receivables | $15M | $16M | $10M | $5M | $267.0K | $6M | $418.0K | $30.0K | $679.0K | $88.0K | |
| Prepaid Expense | $2M | $3M | $8M | $7M | $7M | $11M | $6M | $6M | $2M | $2M | |
| Current Assets | $164M | $289M | $341M | $357M | $507M | $419M | $464M | $375M | $332M | $187M | |
| PP&E (Net) | $4M | $14M | $12M | $16M | $17M | $14M | $11M | $40M | $39M | $40M | |
| PP&E (Gross) | $32M | $46M | $38M | $37M | $33M | $25M | $18M | $47M | $44M | $42M | |
| Accum. Depreciation | $28M | $32M | $26M | $22M | $16M | $11M | $7M | $7M | $4M | $2M | |
| Other Non-current Assets | $3M | $5M | $9M | $5M | $7M | $5M | $5M | $5M | $2M | $2M | |
| Total Assets | $187M | $342M | $499M | $514M | $677M | $573M | $509M | $420M | $373M | $229M | |
| Accounts Payable | $3M | $5M | $8M | $10M | $5M | $6M | $6M | $5M | $4M | $5M | |
| Accrued Liabilities | $33M | $46M | $35M | $31M | $20M | $24M | $22M | $13M | $11M | $17M | |
| Current Liabilities | $46M | $77M | $63M | $60M | $47M | $58M | $60M | $36M | $37M | $33M | |
| Capital Leases | $12M | $20M | $24M | $33M | $16M | $19M | $23M | $32M | $33M | $35M | |
| Other Non-current Liabilities | $3M | $3M | $2M | $0 | · | $28M | $1.0K | $293.0K | $317.0K | $396.0K | |
| Total Liabilities | $159M | $207M | $150M | $154M | $124M | $179M | $246M | $184M | $165M | $95M | |
| Long-term Debt | $59M | $57M | $0 | · | · | · | · | · | · | · | |
| Total Debt | $59M | $57M | · | · | · | · | · | · | · | · | |
| Common Stock | $10.0K | $8.0K | $8.0K | $7.0K | $7.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | |
| Retained Earnings | $-1.63B | $-1.47B | $-1.23B | $-1.08B | $-858M | $-665M | $-549M | $-416M | $-306M | $-186M | |
| AOCI | $0 | $268.0K | $198.0K | $-4M | $-493.0K | $-46.0K | $107.0K | $-29.0K | $-76.0K | · | |
| Stockholders' Equity | $27M | $134M | $349M | $361M | $554M | $394M | $262M | $236M | $208M | $135M | |
| Liabilities + Equity | $187M | $342M | $499M | $514M | $677M | $573M | $509M | $420M | $373M | $229M | |
| Shares Outstanding | 97,866,996 | 82,734,696 | 81,767,263 | 68,847,382 | 68,435,257 | 62,563,457 | 54,355,798 | 48,758,951 | 44,507,960 | 35,818,131 |
नकदी प्रवाह 10
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $21M | $20M | $29M | $43M | $23M | $27M | $27M | $23M | $17M | |
| Restructuring | · | $12M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $-165M | $-210M | $-132M | $-177M | $-164M | $-180M | $-41M | $-46M | $-9M | $-50M | |
| CapEx | $607.0K | $9M | $5M | $4M | $8M | $7M | $6M | $5M | $2M | $3M | |
| Investing Cash Flow | $139M | $162M | $-4M | $114M | $-54M | $-141M | $12M | $-53M | $-184M | $-3M | |
| Stock Issued | $43M | $0 | $117M | $0 | $249M | $204M | $116M | $77M | $154M | $97M | |
| Net Stock Activity | $43M | $0 | $117M | · | $249M | $204M | $116M | $77M | $154M | $97M | |
| Financing Cash Flow | $40M | $56M | $118M | $1M | $282M | $224M | $132M | $87M | $155M | $97M | |
| Net Change in Cash | $14M | $8M | $-18M | $-62M | $64M | $-96M | $103M | $-12M | $-39M | $43M | |
| Free Cash Flow | $-166M | $-219M | $-137M | $-181M | $-172M | $-187M | $-47M | $-50M | $-11M | $-53M |
लाभप्रदता 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% | -148.6% | -686.4% | -356.1% | · | · | |
| Net Margin | -395.0% | -733.7% | -196.1% | -1118.3% | -753.6% | -127.8% | -651.4% | -344.3% | · | · | |
| EBITDA Margin | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% | -148.6% | -686.4% | -356.1% | · | · | |
| ROA | -60.6% | -56.4% | -30.2% | -37.0% | -30.8% | -21.4% | -28.8% | -27.7% | -40.0% | -51.3% | |
| ROE | -688.8% | -153.0% | -43.2% | -56.9% | -33.8% | -27.8% | -56.6% | -47.7% | -70.2% | -377.5% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.7 | 5.4 | 5.9 | 10.8 | 7.2 | 7.7 | 10.4 | 9.1 | 5.7 | |
| Quick Ratio | 3.5 | 3.7 | 5.3 | 5.8 | 10.7 | 7.0 | 7.6 | 10.3 | 9.0 | 5.6 | |
| Debt / Equity | 2.1 | 0.4 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 2.0 | 0.4 | · | · | · | · | · | · | · | · |
दक्षता 2
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | 0.2 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | · | · | |
| Receivables Turnover | 2.6 | 2.4 | 10.2 | 7.3 | 8.1 | 28.1 | 91.7 | 90.1 | · | · |
विकास दरें 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 25.4% | -58.6% | 296.3% | -22.8% | -71.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.2% | 8.2% | -4.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.9% | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41M | $32M | $78M | $20M | $26M | $91M | $21M | $32M | $14M | $6M | |
| Net Income TTM | $-160M | $-237M | $-153M | $-220M | $-193M | $-116M | $-134M | $-110M | $-120M | $-97M | |
| Market Cap | $201M | $105M | $828M | $611M | $1.82B | $4.39B | $1.61B | $1.11B | $1.37B | $581M | |
| Enterprise Value | $113M | $-107M | · | · | · | · | · | · | · | · | |
| P/E | -1.1 | -0.4 | -5.0 | -2.8 | -9.3 | -35.4 | -11.0 | · | · | · | |
| P/S | 5.0 | 3.3 | 10.6 | 31.0 | 71.1 | 48.3 | 78.4 | 34.7 | 99.6 | 96.0 | |
| P/B | 7.4 | 0.8 | 2.4 | 1.7 | 3.3 | 11.1 | 6.1 | 4.7 | 6.6 | 4.3 | |
| P / Tangible Book | 7.4 | 0.8 | 2.4 | 1.7 | 3.3 | 11.1 | · | · | · | · | |
| P / Cash Flow | -1.2 | -0.5 | -6.3 | -3.4 | -11.1 | -24.4 | -39.6 | -24.3 | -145.2 | -11.6 | |
| P / FCF | -1.2 | -0.5 | -6.1 | -3.4 | -10.6 | -23.5 | -34.4 | -22.0 | -119.2 | -10.9 | |
| EV / EBITDA | -0.7 | 0.4 | · | · | · | · | · | · | · | · | |
| EV / FCF | -0.7 | 0.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | -3.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -87.8% | -226.8% | -19.9% | -36.2% | -10.7% | -2.8% | -9.0% | · | · | · |
आय विवरण 12
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | $3M | $25M | $8M | $4M | $5M | $31M | $61.0K | $513.0K | $1M | $60M | $5M | $3M | $10M | $7M | $42.0K | |
| R&D Expense | $20M | $18M | $27M | $20M | $16M | $27M | $49M | $48M | $54M | $49M | $70M | $41M | $30M | $38M | $52M | $41M | |
| SG&A Expense | $12M | $10M | $11M | $12M | $13M | $13M | $16M | $18M | $18M | $19M | $14M | $15M | $17M | $23M | $18M | $16M | |
| Operating Expenses | $30M | $28M | $32M | $32M | $55M | $81M | $77M | $66M | $72M | $68M | $84M | $55M | $47M | $61M | $70M | $58M | |
| Operating Income | $-19M | $-25M | $-8M | $-25M | $-52M | $-76M | $-47M | $-66M | $-72M | $-67M | $-24M | $-50M | $-44M | $-51M | $-63M | $-58M | |
| Other Non-op | $17.0K | $-113.0K | $-5.0K | $-1.0K | $-2M | $-425.0K | $-3.0K | $-5.0K | $-1.0K | $6.0K | $-13.0K | $0 | $-7.0K | $-2M | $-2.0K | $1.0K | |
| Net Income | $-18M | $-25M | $-6M | $-25M | $-53M | $-76M | $-45M | $-62M | $-68M | $-62M | $-19M | $-45M | $-40M | $-49M | $-61M | $-56M | |
| EPS (Basic) | $-0.15 | $-0.26 | $0.03 | $-0.28 | $-0.63 | $-0.92 | $-0.55 | $-0.75 | $-0.82 | $-0.76 | $-0.20 | $-0.55 | $-0.56 | $-0.71 | $-0.88 | $-0.81 | |
| EPS (Diluted) | $-0.15 | $-0.26 | $0.03 | $-0.28 | $-0.63 | $-0.92 | $-0.55 | $-0.75 | $-0.82 | $-0.76 | $-0.20 | $-0.55 | $-0.56 | $-0.71 | $-0.88 | $-0.81 | |
| Shares (Basic) | 119,294,615 | 97,879,343 | -168,811,755 | 90,090,397 | 84,412,200 | 83,055,066 | -164,396,186 | 82,485,199 | 82,310,368 | 81,938,839 | -145,983,475 | 81,648,250 | 71,376,678 | 68,924,180 | -137,197,139 | 68,736,125 | |
| Shares (Diluted) | 119,294,615 | 97,879,343 | -168,811,755 | 90,090,397 | 84,412,200 | 83,055,066 | -164,396,186 | 82,485,199 | 82,310,368 | 81,938,839 | -145,983,475 | 81,648,250 | 71,376,678 | 68,924,180 | -137,197,139 | 68,736,125 | |
| EBITDA | $-19M | $-25M | · | $-25M | $-52M | $-76M | · | $-66M | $-72M | $-67M | · | $-50M | $-44M | $-51M | · | $-58M |
बैलेंस शीट 24
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $182M | $124M | $147M | $166M | $139M | $139M | $132M | $96M | $64M | $69M | $124M | $83M | $221M | $129M | $142M | $211M | |
| Short-term Investments | $30M | · | $0 | $0 | $40M | $82M | $138M | $169M | $215M | $227M | $199M | $267M | $211M | $189M | · | $209M | |
| Receivables | $3M | $3M | $15M | $8M | $588.0K | $510.0K | $16M | $126.0K | $244.0K | $245.0K | $10M | $2M | $2M | $242.0K | · | $120.0K | |
| Prepaid Expense | $4M | $2M | $2M | $3M | $4M | $3M | $3M | $6M | $7M | $9M | $8M | $7M | $7M | $6M | · | $7M | |
| Current Assets | $218M | $128M | $164M | $177M | $183M | $225M | $289M | $271M | $286M | $306M | $341M | $359M | $441M | $324M | · | $427M | |
| PP&E (Net) | $3M | $3M | $4M | $4M | $5M | $8M | $14M | $15M | $14M | $13M | $12M | $12M | $13M | $13M | · | $15M | |
| PP&E (Gross) | $29M | $29M | $32M | $32M | $31M | $36M | $46M | $46M | $43M | $41M | $38M | $37M | $36M | $35M | · | $36M | |
| Accum. Depreciation | $27M | $26M | $28M | $28M | $27M | $28M | $32M | $31M | $29M | $28M | $26M | $25M | $23M | $22M | · | $20M | |
| Other Non-current Assets | $3M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | $8M | $9M | $9M | $6M | $5M | $7M | · | $8M | |
| Total Assets | $237M | $149M | $187M | $202M | $211M | $264M | $342M | $328M | $385M | $440M | $499M | $505M | $542M | $464M | · | $531M | |
| Accounts Payable | $5M | $4M | $3M | $3M | $7M | $5M | $5M | $12M | $14M | $8M | $8M | $10M | $8M | $9M | · | $7M | |
| Accrued Liabilities | $17M | $21M | $33M | $48M | $48M | $47M | $46M | $29M | $28M | $31M | $35M | $30M | $28M | $32M | · | $19M | |
| Current Liabilities | $68M | $40M | $46M | $62M | $66M | $73M | $77M | $72M | $74M | $66M | $63M | $59M | $55M | $57M | · | $42M | |
| Capital Leases | $9M | $11M | $12M | $14M | $15M | $18M | $20M | $22M | $21M | $22M | $24M | $25M | $27M | $29M | · | $9M | |
| Other Non-current Liabilities | $2M | $3M | $3M | $5M | $5M | $6M | $3M | $3M | $4M | $3M | $2M | · | · | · | · | · | |
| Total Liabilities | $132M | $145M | $159M | $188M | $191M | $201M | $207M | $152M | $153M | $146M | $150M | $144M | $142M | $147M | · | $116M | |
| Long-term Debt | $56M | $55M | $59M | $59M | $57M | $55M | $57M | · | · | · | $0 | · | · | · | · | · | |
| Total Debt | $56M | $55M | · | $59M | $57M | $55M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $15.0K | $10.0K | $10.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | · | $7.0K | |
| Retained Earnings | $-1.67B | $-1.65B | $-1.63B | $-1.62B | $-1.60B | $-1.54B | $-1.47B | $-1.42B | $-1.36B | $-1.29B | $-1.23B | $-1.21B | $-1.17B | $-1.13B | · | $-1.02B | |
| AOCI | $-6.0K | $0 | $0 | $0 | $15.0K | $88.0K | $268.0K | $522.0K | $-442.0K | $-326.0K | $198.0K | $-1M | $-2M | $-2M | · | $-4M | |
| Stockholders' Equity | $105M | $4M | $27M | $13M | $19M | $62M | $134M | $176M | $232M | $294M | $349M | $360M | $400M | $317M | $361M | $415M | |
| Liabilities + Equity | $237M | $149M | $187M | $202M | $211M | $264M | $342M | $328M | $385M | $440M | $499M | $505M | $542M | $464M | · | $531M | |
| Shares Outstanding | 97,866,996 | 97,866,996 | 97,866,996 | 93,264,421 | 87,388,425 | 83,709,536 | 82,734,696 | 82,538,624 | 82,429,514 | 82,234,951 | 81,767,263 | 81,668,796 | 81,616,909 | 68,993,591 | · | 68,761,729 |
नकदी प्रवाह 10
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $5M | $5M | $8M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Restructuring | · | · | · | · | · | $53M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-30M | $-23M | $-36M | $-31M | $-50M | $-48M | $-51M | $-53M | $-57M | $-50M | $-22M | $-35M | $-39M | $-36M | $-42M | $-48M | |
| CapEx | $106.0K | $92.0K | $60.0K | $433.0K | $0 | $114.0K | $540.0K | $3M | $3M | $2M | $1M | $239.0K | $1M | $2M | $624.0K | $614.0K | |
| Investing Cash Flow | $-30M | $64.0K | $58.0K | $40M | $43M | $56M | $31M | $84M | $52M | $-5M | $63M | $-103M | $13M | $23M | $-28M | $89M | |
| Stock Issued | $117M | $0 | $17M | $17M | $7M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | · | |
| Net Stock Activity | · | $0 | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $118M | $0 | $17M | $17M | $7M | $-1M | $56M | $0 | $322.0K | $192.0K | $514.0K | $0 | $118M | $0 | $619.0K | $80.0K | |
| Net Change in Cash | $58M | $-23M | $-19M | $26M | $-150.0K | $7M | $36M | $31M | $-5M | $-54M | $41M | $-138M | $92M | $-13M | $-69M | $41M | |
| Free Cash Flow | · | $-23M | · | · | · | $-48M | · | · | · | $-52M | · | · | · | $-38M | · | · |
लाभप्रदता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -156.1% | -883.2% | · | -325.4% | -1440.6% | -1635.1% | · | -107649.2% | -14016.2% | -5902.3% | · | -940.1% | -1527.3% | -517.3% | · | -136952.4% | |
| Net Margin | -153.3% | -882.4% | · | -333.0% | -1487.8% | -1633.5% | · | -101870.5% | -13178.8% | -5458.1% | · | -843.7% | -1395.6% | -497.8% | · | -132681.0% | |
| EBITDA Margin | -156.1% | -883.2% | · | -325.4% | -1440.6% | -1635.1% | · | -107649.2% | -14016.2% | -5902.3% | · | -940.1% | -1527.3% | -517.3% | · | -136952.4% | |
| ROA | -8.1% | -12.1% | · | -9.5% | -17.9% | -21.6% | · | -14.9% | -14.6% | -13.7% | · | -8.7% | -7.2% | -9.0% | · | -8.9% | |
| ROE | -29.3% | -74.8% | · | -26.6% | -42.4% | -42.6% | · | -23.2% | -21.4% | -20.2% | · | -11.6% | -9.3% | -11.8% | · | -11.1% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.2 | · | 2.9 | 2.8 | 3.1 | · | 3.7 | 3.9 | 4.6 | · | 6.1 | 8.1 | 5.7 | · | 10.1 | |
| Quick Ratio | 3.1 | 3.2 | · | 2.8 | 2.7 | 3.0 | · | 3.7 | 3.8 | 4.5 | · | 6.0 | 8.0 | 5.6 | · | 9.9 | |
| Debt / Equity | 0.5 | 12.4 | · | 4.4 | 3.0 | 0.9 | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 10.7 | · | 4.0 | 2.7 | 0.8 | · | · | · | · | · | · | · | · | · | · |
दक्षता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 7.2 | 1.8 | · | 1.8 | 8.6 | 12.3 | · | 0.0 | 0.4 | 4.7 | · | 4.2 | 1.9 | 12.2 | · | 0.2 |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $26M | $19M | · | $16M | $9M | $6M | · | $7M | $10M | $19M | · | $18M | $19M | $23M | · | $19M | |
| Net Income TTM | $-122M | $-179M | · | $-217M | $-259M | $-268M | · | $-237M | $-215M | $-196M | · | $-190M | $-199M | $-209M | · | $-199M | |
| Market Cap | $317M | $242M | · | $324M | $192M | $97M | · | $281M | $385M | $610M | · | $637M | $672M | $500M | · | $842M | |
| Enterprise Value | $161M | $173M | · | $217M | $70M | $-69M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -1.2 | · | -1.3 | -0.7 | -0.4 | · | -1.2 | -1.7 | -2.9 | · | -3.0 | -2.9 | -2.4 | · | -4.2 | |
| P/S | 12.3 | 13.0 | · | 20.4 | 21.8 | 15.3 | · | 40.0 | 39.0 | 31.8 | · | 35.2 | 35.1 | 21.7 | · | 43.4 | |
| P/B | 3.0 | 54.8 | · | 24.1 | 10.0 | 1.6 | · | 1.6 | 1.7 | 2.1 | · | 1.8 | 1.7 | 1.6 | · | 2.0 | |
| P / Tangible Book | 3.0 | 54.8 | · | 24.1 | 10.0 | 1.6 | · | 1.6 | 1.7 | 2.1 | · | 1.8 | 1.7 | 1.6 | · | 2.0 | |
| P / Cash Flow | · | -10.5 | · | · | · | -2.0 | · | · | · | -12.2 | · | · | · | -14.0 | · | · | |
| P / FCF | · | -10.4 | · | · | · | -2.0 | · | · | · | -11.8 | · | · | · | -13.3 | · | · | |
| EV / EBITDA | -8.7 | -6.9 | · | -8.8 | -1.4 | 0.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | -7.5 | · | · | · | 1.4 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 6.2 | 9.3 | · | 13.7 | 8.0 | -10.9 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -40.7% | -84.6% | · | -74.4% | -141.8% | -280.2% | · | -84.5% | -57.6% | -34.8% | · | -33.7% | -34.8% | -41.9% | · | -23.7% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $41M | $32M | $78M | $20M | $26M |
| परिचालन मार्जिन % | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% |
| शुद्ध आय | $-160M | $-237M | $-153M | $-220M | $-193M |
| तनुकरणित EPS | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 2.1 | 0.4 | — | — | — |
| वर्तमान अनुपात | 3.5 | 3.7 | 5.4 | 5.9 | 10.8 |
| त्वरित अनुपात | 3.5 | 3.7 | 5.3 | 5.8 | 10.7 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $-166M | $-219M | $-137M | $-181M | $-172M |
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 239 फाइलर्स · $327.2M कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 37 (-6 पिछली तिमाही की तुलना में) | 22 (-4 पिछली तिमाही की तुलना में) | 79 (+23 पिछली तिमाही की तुलना में) | 42 (-9 पिछली तिमाही की तुलना में) | +67.4M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $36000000 | 11111111 | 11.00% | शेयर |
| RA CAPITAL MANAGEMENT, L.P. | $28800360 | 8889000 | 8.80% | शेयर |
| Commodore Capital LP | $28800360 | 8889000 | 8.80% | शेयर |
| ADAR1 Capital Management, LLC | $28800360 | 8889000 | 8.80% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $19897929 | 6141336 | 6.08% | शेयर |
| Paradigm Biocapital Advisors LP | $18100665 | 5586625 | 5.53% | शेयर |
| Opaleye Management Inc. | $12512653 | 3861930 | 3.82% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $11658618 | 3598339 | 3.56% | शेयर |
| Woodline Partners LP | $11519810 | 3555497 | 3.52% | शेयर |
| Vivo Capital, LLC | $11519010 | 3555250 | 3.52% | शेयर |
| GordonMD Global Investments LP | $10131480 | 3127000 | 3.10% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $7999298 | 2468919 | 2.45% | शेयर |
| Logos Global Management LP | $7199280 | 2222000 | 2.20% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $7134030 | 2201290 | 2.18% | शेयर |
| STATE STREET CORP | $7101442 | 2191803 | 2.17% | शेयर |
| GOLDMAN SACHS GROUP INC | $6763843 | 2087606 | 2.07% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $4318842 | 1332976 | 1.32% | शेयर |
| Seven Fleet Capital Management LP | $4310820 | 1330500 | 1.32% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $4201156 | 1296653 | 1.28% | शेयर |
| MARSHALL WACE, LLP | $4044048 | 1248163 | 1.24% | शेयर |
| D. E. Shaw & Co., Inc. | $3715178 | 1146660 | 1.14% | शेयर |
| KENNEDY CAPITAL MANAGEMENT LLC | $3344111 | 1032133 | 1.02% | शेयर |
| MACKENZIE FINANCIAL CORP | $2844856 | 878042 | 0.87% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2812424 | 868032 | 0.86% | शेयर |
| Nantahala Capital Management, LLC | $2762748 | 852700 | 0.84% | शेयर |
| TWO SIGMA ADVISERS, LP | $2509405 | 1224100 | 0.77% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $2407158 | 742950 | 0.74% | शेयर |
| BlackRock, Inc. | $1813920 | 559852 | 0.55% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $1616750 | 498997 | 0.49% | शेयर |
| Susquehanna Portfolio Strategies, LLC | $1545801 | 477099 | 0.47% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1521180 | 469500 | 0.46% | कॉल ऑप्शन |
| Eversept Partners, LP | $1486541 | 458809 | 0.45% | शेयर |
| Casdin Capital, LLC | $1441800 | 445000 | 0.44% | शेयर |
| PEAK6 LLC | $1346029 | 415441 | 0.41% | शेयर |
| DIADEMA PARTNERS LP | $1296000 | 400000 | 0.40% | कॉल ऑप्शन |
| BIT Capital GmbH | $1056240 | 326000 | 0.32% | शेयर |
| Cubist Systematic Strategies, LLC | $994094 | 286482 | 0.30% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $878642 | 271186 | 0.27% | शेयर |
| BANK OF AMERICA CORP /DE/ | $751119 | 231827 | 0.23% | शेयर |
| LPL Financial LLC | $748813 | 231115 | 0.23% | शेयर |
| Erste Asset Management GmbH | $736000 | 230000 | 0.22% | शेयर |
| IEQ CAPITAL, LLC | $705623 | 217785 | 0.22% | शेयर |
| Walleye Capital LLC | $595703 | 183859 | 0.18% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $558900 | 172500 | 0.17% | पुट ऑप्शन |
| CITADEL ADVISORS LLC | $557604 | 172100 | 0.17% | पुट ऑप्शन |
| DAFNA Capital Management LLC | $552323 | 170470 | 0.17% | शेयर |
| Mariner, LLC | $548500 | 169291 | 0.17% | शेयर |
| Green Alpha Advisors, LLC | $505589 | 156046 | 0.15% | शेयर |
| PEAK6 LLC | $497340 | 153500 | 0.15% | कॉल ऑप्शन |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $490555 | 151406 | 0.15% | शेयर |
| BARCLAYS PLC | $476030 | 146923 | 0.15% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $464187 | 187930 | 0.14% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $445030 | 137355 | 0.14% | शेयर |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $408240 | 126000 | 0.12% | शेयर |
| Point72 Asset Management, L.P. | $405758 | 125234 | 0.12% | शेयर |
| RHUMBLINE ADVISERS | $380421 | 117417 | 0.12% | शेयर |
| JPMORGAN CHASE & CO | $376528 | 117665 | 0.12% | शेयर |
| JANE STREET GROUP, LLC | $374473 | 115578 | 0.11% | शेयर |
| FMR LLC | $348384 | 107526 | 0.11% | शेयर |
| HSBC HOLDINGS PLC | $314481 | 97062 | 0.10% | शेयर |
| Bank of New York Mellon Corp | $309378 | 95487 | 0.09% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $303462 | 93661 | 0.09% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $300818 | 92845 | 0.09% | शेयर |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $300226 | 92094 | 0.09% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $300011 | 92596 | 0.09% | शेयर |
| CWM, LLC | $259352 | 105001 | 0.08% | शेयर |
| MORGAN STANLEY | $237324 | 73248 | 0.07% | शेयर |
| CITADEL ADVISORS LLC | $229392 | 70800 | 0.07% | कॉल ऑप्शन |
| OSAIC HOLDINGS, INC. | $222928 | 68806 | 0.07% | शेयर |
| SEI INVESTMENTS CO | $221188 | 68268 | 0.07% | शेयर |
| Nuveen, LLC | $221188 | 68268 | 0.07% | शेयर |
| Joel Isaacson & Co., LLC | $220787 | 68144 | 0.07% | शेयर |
| JANE STREET GROUP, LLC | $218376 | 67400 | 0.07% | पुट ऑप्शन |
| SIMPLEX TRADING, LLC | $207275 | 63974 | 0.06% | शेयर |
| MetLife Investment Management, LLC | $182140 | 56216 | 0.06% | शेयर |
| CITIGROUP INC | $182052 | 56189 | 0.06% | शेयर |
| CITADEL ADVISORS LLC | $173923 | 53680 | 0.05% | शेयर |
| MML INVESTORS SERVICES, LLC | $168765 | 52088 | 0.05% | शेयर |
| GROUP ONE TRADING LLC | $163131 | 50349 | 0.05% | शेयर |
| Creative Planning | $147653 | 45572 | 0.05% | शेयर |
| China Universal Asset Management Co., Ltd. | $143934 | 44424 | 0.04% | शेयर |
| WINTON GROUP Ltd | $141588 | 43700 | 0.04% | शेयर |
| Vanguard Global Advisers, LLC | $138876 | 42863 | 0.04% | शेयर |
| CANADA PENSION PLAN INVESTMENT BOARD | $137376 | 42400 | 0.04% | शेयर |
| Graham Capital Management, L.P. | $134369 | 41472 | 0.04% | शेयर |
| Quinn Opportunity Partners LLC | $129600 | 40000 | 0.04% | शेयर |
| Invesco Ltd. | $128178 | 39561 | 0.04% | शेयर |
| Vanguard Personalized Indexing Management, LLC | $124108 | 38305 | 0.04% | शेयर |
| MERCER GLOBAL ADVISORS INC /ADV | $121967 | 37644 | 0.04% | शेयर |
| Balyasny Asset Management L.P. | $121947 | 37638 | 0.04% | शेयर |
| AXQ CAPITAL, LP | $118104 | 36452 | 0.04% | शेयर |
| Nuveen Asset Management, LLC | $113934 | 89712 | 0.03% | शेयर |
| SCS Capital Management LLC | $113400 | 35000 | 0.03% | शेयर |
| Police & Firemen's Retirement System of New Jersey | $109749 | 33873 | 0.03% | शेयर |
| Thrive Wealth Management, LLC | $108540 | 33500 | 0.03% | शेयर |
| TWO SIGMA SECURITIES, LLC | $107367 | 33138 | 0.03% | शेयर |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $102359 | 31207 | 0.03% | शेयर |
| CAPTRUST FINANCIAL ADVISORS | $98159 | 30296 | 0.03% | शेयर |
| HORIZON KINETICS ASSET MANAGEMENT LLC | $89683 | 27680 | 0.03% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $88339 | 27265 | 0.03% | शेयर |
कंपनी के अंदरूनी सूत्र 34 इनसाइडर्स · 15 अधिकारी · 16 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Gilmore Neil O'Neill | CEO | 3 जून 2026 S | 248313 | 0 | 1 | $-41543 |
| MULLEN JAMES C | CEO | 14 अप्रैल 2022 A | 75898 | 0 | 0 | $0 |
| Cynthia Collins | CEO | 9 फ़रवरी 2021 S | 43760 | 0 | 0 | $0 |
| Katrine Bosley | President and CEO | 8 जनवरी 2019 S | 1204966 | 0 | 0 | $0 |
| Erick Lucera | EVP, CHIEF FINANCIAL OFFICER | 17 मई 2023 A | 77900 | 0 | 0 | $0 |
| Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | 11 मई 2023 S | 106610 | 0 | 0 | $0 |
| Andrew A. F. Hack | Chief Financial Officer | 4 फ़रवरी 2019 M | 0 | 0 | 0 | $0 |
| Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | 28 जुलाई 2026 S | 62369 | 0 | 2 | $-15133 |
| Bruce Eaton | EVP, CBO AND CTO | 11 अगस्त 2023 S | 75831 | 0 | 0 | $0 |
| Baisong Mei | SVP, CHIEF MEDICAL OFFICER | 19 जुलाई 2023 S | 72055 | 0 | 0 | $0 |
| Mark S Shearman | EVP, CHIEF SCIENTIFIC OFFICER | 13 फ़रवरी 2023 S | 65559 | 0 | 0 | $0 |
| Lisa Anne Michaels | EVP/Chief Medical Officer | 22 दिसमबर 2021 A | 22675 | 0 | 0 | $0 |
| Judith R Abrams | Chief Medical Officer | 28 अक्टूबर 2019 A | 25000 | 0 | 0 | $0 |
| Vickesh Myer | Chief Technology Officer | 18 मार्च 2019 M | 0 | 0 | 0 | $0 |
| Gerald Frank Cox | Chief Medical Officer | 7 फ़रवरी 2018 A | 4000 | 0 | 0 | $0 |
| Elliott M. Levy | निदेशक | 17 जून 2026 A | — | 0 | 0 | $0 |
| David Scadden | निदेशक | 17 जून 2026 A | — | 0 | 0 | $0 |
| Bernadette Connaughton | निदेशक | 17 जून 2026 A | — | 0 | 0 | $0 |
| Jessica Hopfield | निदेशक | 17 जून 2026 A | 22700 | 0 | 0 | $0 |
| Andrew Hirsch | निदेशक | 17 जून 2026 A | — | 0 | 0 | $0 |
| Meeta Chatterjee | निदेशक | 1 जून 2023 A | — | 0 | 0 | $0 |
| Emma Reeve | निदेशक | 1 जून 2023 A | — | 0 | 0 | $0 |
| Akshay Vaishnaw | निदेशक | 1 जून 2023 A | — | 0 | 0 | $0 |
| Boris Nikolic | निदेशक | 15 जून 2018 A | 35000 | 0 | 0 | $0 |
| Douglas G. Cole | निदेशक | 17 अगस्त 2017 J | 3171 | 0 | 0 | $0 |
| Kevin Bitterman | निदेशक | 15 जून 2017 A | 2797144 | 0 | 0 | $0 |
| Alexis Borisy | निदेशक | 15 जून 2017 A | 0 | 0 | 0 | $0 |
| John Mendlein | निदेशक | 15 जून 2017 A | — | 0 | 0 | $0 |
| Kevin P Starr | 10% मालिक | 6 सितमबर 2016 S | 0 | 0 | 0 | $0 |
| bng0, LLC | 10% मालिक | 8 फ़रवरी 2016 C | 2649572 | 0 | 0 | $0 |
| Patrick Thomas Ellinor II | — | 6 अगस्त 2026 A | — | 0 | 0 | $0 |
| Amy Parison | — | 3 अगस्त 2026 S | 14292 | 0 | 2 | $-3002 |
| Charles Albright | — | 15 दिसमबर 2020 M | 24907 | 0 | 0 | $0 |
| Alexandra Glucksmann | — | 15 मार्च 2017 M | 117788 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 1 होल्डिंग
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Polaris Venture Partners VI, L.P. (“PVP VI”), Polaris Venture Founders’ Fund VI, L.P. (“PVPFF VI”), Polaris Venture Management Co. VI, L.L.C. (“PVM VI”), Jonathan A. Flint (“Flint”), Terrance G. McGuire (“McGuire”), Brian Chee (“Chee”), David Barrett (“Barrett”), Amir Nashat (“Nashat”), Bryce Youngren (“Youngren”) ×4 फाइलिंग | 18 सितमबर 2017 | — | प्रारंभिक फाइलिंग | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 30 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.42% | 32319 SH | 21 अगस्त 2026 | दैनिक |
| NXTE · INVESTMENT MANAGERS SERIES TRUST II | 0.35% | 61197 NS | 30 जून 2026 | N-PORT |
| GNOM · Global X Funds | 0.34% | 54725 NS | 31 मई 2026 | N-PORT |
| IWC · iShares Trust | 0.07% | 346478 SH | 21 अगस्त 2026 | दैनिक |
| IBB · iShares Trust | 0.03% | 1053931 SH | 21 अगस्त 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.03% | 8933 SH | 21 अगस्त 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 96927 SH | 19 अगस्त 2026 | दैनिक |
| BIB · ProShares Trust | 0.02% | 3611 NS | 31 मई 2026 | N-PORT |
| IWO · iShares Trust | 0.02% | 844017 SH | 21 अगस्त 2026 | दैनिक |
| TMFX · RBB Fund, Inc. | 0.02% | 1527 NS | 31 मई 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 118731 SH | 21 अगस्त 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 575834 SH | 19 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.01% | 461967 SH | 19 अगस्त 2026 | दैनिक |
| IWM · iShares Trust | 0.01% | 2595929 SH | 21 अगस्त 2026 | दैनिक |
| RSSL · Global X Funds | 0.01% | 42610 NS | 30 अप्रैल 2026 | N-PORT |
| RB · ProShares Trust | 0.01% | 29 NS | 31 मई 2026 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 4633 NS | 31 मई 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 476309 NS | 31 मई 2026 | N-PORT |
| UWM · ProShares Trust | 0.01% | 3622 NS | 31 मई 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 32379 NS | 31 मई 2026 | N-PORT |
| URTY · ProShares Trust | 0.00% | 3660 NS | 31 मई 2026 | N-PORT |
| IWN · iShares Trust | 0.00% | 120487 SH | 21 अगस्त 2026 | दैनिक |
| HDG · ProShares Trust | 0.00% | 92 NS | 31 मई 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2922 NS | 31 मई 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 96350 NS | 31 मई 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 19062 SH | 21 अगस्त 2026 | दैनिक |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1100306 SH | 19 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4890144 SH | 19 अगस्त 2026 | दैनिक |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9046 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7608 SH | 19 अगस्त 2026 | दैनिक |